Key Takeaways Tempus AI's fourth-quarter results missed estimates as its costs increased.The medical technology firm's ...
We recently published a list of 10 AI Stocks on Analysts’ Radar As AI Spending Grows. In this article, we are going to take a ...
Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and ...
Tempus AI Inc (NASDAQ:TEM) shares are trading lower Tuesday after the company reported mixed fourth-quarter financial results ...
Tempus AI (TEM) plunged Tuesday as its quarterly revenues missed expectations, days after insiders were reported as offloading the stock in big ...
Despite filing a fourth-quarter and yearend 2024 earnings report that the CEO described as "fantastic" yesterday afternoon, ...
Tempus AI (TEM) stock dropped 19% Tuesday, the day after the company released a Q4 earnings report that missed Street estimates and its 2025 financial forecast. Read more here.
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.
EST Tempus AI (TEM) files to sell 4.84M shares of Class A common stock for holdersDiscover the Best Stocks and Maximize Your Portfolio: ...
1d
24/7 Wall St. on MSNNancy Pelosi's Latest AI Stock Pick Tempus AI Is Up Big TodayTempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financia ...
Tempus AI saw its loss narrow in the fourth quarter despite booking higher costs and seeing a surge in revenue in the period. Shares fell 8.3% to $64 in post-market trading. Through Monday's close, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results